Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hisun Braces For Hit From US FDA Import Alert

This article was originally published in PharmAsia News

Executive Summary

Zhejiang Hisun Pharmaceutical has already seen its net profit slump this year, and now has to face a US import alert for APIs made at one of its Chinese plants on top of a voluntarily quarantine by importers in Canada. The company is nevertheless pushing ahead with the reconstruction of its business model, eyeing global partners for future markets.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register